.@POTUS called for creative solutions to make medicines more affordable for U.S. patients. We’re proud to launch AmgenNow™ for U.S. patients to affordably access our medicines, starting with our innovative cardiovascular medicine at a 60% lower price for patients living with CV

On U.S. Manufacturing Day and every day, Amgen Operations is working to deliver for every patient, every time.

📢NEWS: Amgen announces topline results from its Phase 3 trial evaluating cardiovascular outcomes in high-risk patients without prior heart attack or stroke. Full data readout at @American_Heart Scientific Sessions #AHA25. 🔗 Learn more: https://t.co/yq59tLVXgr $AMGN

Celebrating +10 years of cardiovascular innovation 💙 For over a decade, Amgen has been championing science-led innovation in the fight against cardiovascular disease, guided by doing what's right for patients. 🔗 Learn more: https://t.co/E4L7Iq223P

Amgen today announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs. This expansion at our Puerto Rico facility builds on more than $40B Amgen has invested in U.S. manufacturing and R&D since 2018, enabled by pro-growth policies under

Amgen today announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs. This expansion at our Puerto Rico facility builds on more than $40B Amgen has invested in U.S. manufacturing and R&D since 2018. 🔗 Details: https://t.co/zC65qbYbOO

Susan Sweeney, EVP, Obesity and Related Conditions, has been appointed to the Steering Committee for the @MilkenInstitute Women's Health Network. 🎉 🔗 Read about her path & vision as a champion for addressing women’s health to improve public health:

Check out what our obesity and related conditions team is up to at this year’s @EASDNews! Swipe to see what you can expect at #EASD2025. ➡️

We remember Dora Menchaca, an Amgen scientist, mentor, mother, and wife who was aboard Flight 77 on September 11. At our Thousand Oaks headquarters, a bronze sculpture in her honor stands as a place of reflection. Today, we pause to honor her and all the lives lost.

Amgen joins the global scientific community in mourning the loss of Dr. David Baltimore, Nobel Prize-winning scientist and Amgen Board member whose pioneering work transformed modern biology. 🔗 https://t.co/cO2MorvguU

A fracture is a warning sign. Yet too many postmenopausal women don't get the follow-up care they need. At @ASBMR, we're uniting with global leaders to help close this critical care gap. #ASBMR2025

Explore the latest real-world evidence at @ASBMR! See recent data on osteoporosis care for postmenopausal women: 📅 Sept. 5 | ⏰ 11 a.m. PDT 📍 Location Fri-1012 | Oral Presentation Session

Amgen has been ranked first among pharma peer companies and third overall by U.S. patient groups in the 2024 @PatientView Survey. We’re proud to be recognized for our commitment to patient centricity, integrity, and long-term collaboration. Our recent Advocacy Summit reinforced

🧬🔍📊 Curious how genetic data and biological discoveries from Amgen scientists in labs across Reykjavik, Iceland and Thousand Oaks, California, helped lay the groundwork for our lead #obesity asset? Dive into the latest https://t.co/mKpkeMiSp8 story:

We are proud that Amgen’s new, half a billion-dollar state-of-the-art Center for Science and Innovation creates hundreds of U.S. jobs at our U.S. headquarters. This follows other U.S. focused manufacturing investments announced in 2025 in Ohio and North Carolina. 🔗